Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. - Wikidata - awgldk - TriplyDB

Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial.

Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial.

http://www.wikidata.org/entity/Q44212007

about

A Case Based Approach to Clinical Genetics of Thoracic Aortic Aneurysm/Dissection.Marfan syndrome: current perspectives Large animal models of cardiovascular disease Medical treatment of aortic aneurysms in Marfan syndrome and other heritable conditions Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis Repurposing of approved cardiovascular drugs Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis No beneficial effect of general and specific anti-inflammatory therapies on aortic dilatation in Marfan mice The Genetics of Aortopathies in Clinical Cardiology.Identification of Hic-5 as a novel scaffold for the MKK4/p54 JNK pathway in the development of abdominal aortic aneurysms.The revised role of TGF-β in aortic aneurysms in Marfan syndrome COMPARE and Pediatric Heart Network Investigator trials: Losartan finally validated in humans with Marfan, but much work remains!Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome Atenolol versus losartan in children and young adults with Marfan's syndrome.Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaborat Clonal expansion of T cells in abdominal aortic aneurysm: a role for doxycycline as drug of choice?Aortic Function's Adaptation in Response to Exercise-Induced Stress Assessing by 1.5T MRI: A Pilot Study in Healthy Volunteers Epidemiology and Medication Utilization Pattern of Aortic Dissection in Taiwan: A Population-Based Study Sparse Redundancy Analysis of High Dimensional Genetic and Genomic Data.The Beneficial Effect of Renin-Angiotensin-Aldosterone System Blockade in Marfan Syndrome Patients after Aortic Root Replacement.Analysis of Strengths, Weaknesses, Opportunities, and Threats as a Tool for Translating Evidence into Individualized Medical Strategies (I-SWOT).Histopathology of aortic complications in bicuspid aortic valve versus Marfan syndrome: relevance for therapy?Hereditary Influence in Thoracic Aortic Aneurysm and Dissection.The effect of losartan therapy on ventricular function in Marfan patients with haploinsufficient or dominant negative FBN1 mutations Aortic aneurysms in Loeys-Dietz syndrome - a tale of two pathways?Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome.Marfan Syndrome: Clinical, Surgical, and Anesthetic Considerations.Diagnosis and treatment of Marfan syndrome: an update.Cardiovascular manifestations in Marfan syndrome and related diseases; multiple genes causing similar phenotypes.Aneurysmal dilatation of the aortic sinuses of Valsalva -- beyond Marfan syndrome: a single centre experience and review of the literature.The evolution of surgical and medical treatment of aortic root aneurysm.Thoracic aortopathies in the military patient.A healthy tension in translational research.Diagnosis and Management of Thoracic Aortic Disease.Variable severity of cardiovascular phenotypes in patients with an early-onset form of Marfan syndrome harboring FBN1 mutations in exons 24-32.Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall.Pathophysiology of aortic aneurysm: insights from human genetics and mouse models.Aetiology and management of hereditary aortopathy.TGF-β Family Signaling in Connective Tissue and Skeletal Diseases.Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model

P2860

Q26744537-5A25101D-BA42-4E13-9344-768676D4B995 Q26747739-559A9798-59F0-44E1-976F-2CB5907AE152 Q26766350-EE9FB01F-A161-4A80-80C4-045AD09806CF Q26823672-ED35DD09-5396-4988-B686-5D91BA4DE2A7 Q26828458-1579E927-CFB9-4B4E-A62E-093771B60447 Q28074453-9B26C5A9-C2D8-42A0-BE5D-3A9CBA518717 Q28240167-C1E91D4D-60CA-420D-AF62-58A8772F040C Q28543088-03608321-4B05-455B-B9FF-E7343226AA91 Q33758342-B1937B6A-E620-4E0B-9990-B0B628C68D07 Q35021833-E19640A2-59B7-4A5A-861C-D456B5EFD2ED Q35044636-015ABF12-CEB2-44D1-A467-A365842C4ACE Q35165097-E8AB4F88-FF5D-46EA-B7A6-0D06CC49CA67 Q35224497-D11D7C7D-4113-4EB6-A5A6-E1064C4D8C54 Q35282583-F756DFEC-717F-4B8B-86B6-D55B6DD858FB Q35628022-856FF7EF-9606-43B1-849E-0D5C2DD87291 Q35723666-C28BEE64-D4CD-4043-8E2A-C0C70AEC4243 Q36054288-F6FF09C0-FEB3-4C3D-92B4-12CCFBC94CE6 Q36194847-4004849C-FE93-4EBC-925C-BFEDBC320448 Q36399382-47B29D6F-CBE8-470C-9110-7F79C3684A57 Q36418768-BD2534BE-138A-4E91-9DA4-EFC28F15E864 Q36763939-91DC7FC2-4462-4FB3-9E82-5C192B8D1719 Q36849812-0AE2DE65-C958-43E6-8279-AE07AA5E23F4 Q37272866-CC2199A7-08DE-4702-BE79-E89F71626EEA Q37341800-79A4AF0A-751E-40D5-BD6A-B630114F078F Q37410646-66BFD15D-DB35-4A3C-B946-016C7C241C8C Q37602214-894E7073-F2F6-4AC3-AA1E-47FBEF84B26C Q38169124-63FD3A61-2D94-467E-82B9-1B51BFD5E7CF Q38207922-62EFF474-842B-401E-9AE3-9BF99BBEECD0 Q38215407-695753BD-A9EE-4BE1-AE99-30CD074BF460 Q38274806-FB9C5A91-027B-45D1-AEA3-DC712281C8E7 Q38274808-A018D257-8653-46BF-BC5A-825CBA76E443 Q38561087-4E591BB6-2D49-4D12-B330-58331B9DBE8A Q38592372-9F31BFD6-B225-4B0A-A72E-4AC6C21C26EC Q38607481-272DFA6D-7358-4A9E-ABFC-1F4A7066AE8E Q38706381-832FC2E8-585E-4D43-A287-A58F2FBF4A60 Q38930482-555077CA-4828-4037-B4F4-1AFD7A56B655 Q39030430-EE3A3FA4-D23E-4A2C-9169-F0FBEEB79D99 Q39094762-BDA1AB04-3C84-4BB4-BC4A-76E3A4519C45 Q39155183-7140DB19-6AA4-4C1C-8428-4FE407B4AF0E Q39694748-64B75570-8BC3-4BAB-A1D0-DC403E9DA87E

P2860

Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial.

http://www.wikidata.org/entity/Q44212007

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Losartan reduces aortic dilata ...... a randomized controlled trial.

@en

Losartan reduces aortic dilata ...... a randomized controlled trial.

@nl

type

label

Losartan reduces aortic dilata ...... a randomized controlled trial.

@en

Losartan reduces aortic dilata ...... a randomized controlled trial.

@nl

prefLabel

Losartan reduces aortic dilata ...... a randomized controlled trial.

@en

Losartan reduces aortic dilata ...... a randomized controlled trial.

@nl

P1433

Q44212007-98AA5990-977E-417B-A37C-6CB54B5E26BE

P1476

Q44212007-8329F6E2-3693-44DB-BAD6-E51B278B306E

P2093

Q44212007-1882CA20-90CA-437A-B0A8-26DC27583B95

Q44212007-18B9D906-5A84-47B0-A3B6-2575134A402A

Q44212007-4D890429-0BCD-4120-94AF-0FE4A0946900

Q44212007-66F848EA-306A-4F81-B80C-ECAE12CE5A62

Q44212007-69D54CFC-966A-4413-82BA-9DA06A9E49F2

Q44212007-76E0C4AB-38D7-44B3-BF31-8087905FD814

Q44212007-93893743-7C61-4632-9D58-12F07393D82B

Q44212007-A94D3372-F0A9-4EB1-A5FD-80047A0958D8

Q44212007-B04053FB-7E7C-43F6-BE23-D7EB7EC9166D

Q44212007-CFFCC244-AE2C-42AF-ACF2-5AB6BB7267D9

P2860

Q44212007-091D70A9-318D-4DC6-88B8-DE3ACE534811

Q44212007-1040F22A-30B2-43FC-B9A2-CA355801D430

Q44212007-187507FB-0C96-4841-8805-21863C613C69

Q44212007-22014660-E4FF-4557-8382-1CB91D5E8566

Q44212007-259D1D11-F79D-4535-8C9F-4FAA059EAF4E

Q44212007-2EB46C87-323C-4044-A44E-0B6FD432A243

Q44212007-466010D0-FEE8-4344-ACF0-B76B131510EC

Q44212007-476F9D72-C6C0-49A7-9F5D-D43ECF219E83

Q44212007-47E23D3B-4E5A-4195-8B11-05BD21D73EF4

Q44212007-645D6E7E-1053-4167-BC62-D0B7AFAC1988

P304

Q44212007-8E6C9516-F8A7-4407-B8B4-F9643752CA76

P31

Q44212007-05C249BE-9857-4082-AAD1-C52E485C59BE

P356

Q44212007-71831815-DFF2-4545-8F7B-FFEF8502398C

P433

Q44212007-AEC1811C-A725-4B5D-915E-05F82CC61F23

P478

Q44212007-2962F8B3-DB92-445B-88C2-87C75F5C9897

P50

Q44212007-06BCF2B3-35AD-4F91-9232-CCE2624F23E0

P577

Q44212007-8566F647-5C54-4F2D-ABBB-B5F1BC24C626

P5875

Q44212007-733F3004-BB83-4260-822C-A3DCCBEC8F15

P698

Q44212007-D0D1D811-6904-4D57-B518-6FE9868B063B

P356

P1433

European Heart Journal

P1476

Losartan reduces aortic dilata ...... a randomized controlled trial.

@en

P2093

Aeilko H Zwinderman

http://www.w3.org/2001/XMLSchema#string

Alexander W den Hartog

http://www.w3.org/2001/XMLSchema#string

Anje M Spijkerboer

http://www.w3.org/2001/XMLSchema#string

Arthur J Scholte

http://www.w3.org/2001/XMLSchema#string

Barbara J M Mulder

http://www.w3.org/2001/XMLSchema#string

Henk A Marquering

http://www.w3.org/2001/XMLSchema#string

Janneke Timmermans

http://www.w3.org/2001/XMLSchema#string

Maarten Groenink

http://www.w3.org/2001/XMLSchema#string

Maarten P van den Berg

http://www.w3.org/2001/XMLSchema#string

Teodora Radonic

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome

Forest plots: trying to see the wood and the trees

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

The molecular genetics of Marfan syndrome and related disorders

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

Angiotensin II type 1 receptor blockers.

CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results.

Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideli

Inflammation aggravates disease severity in Marfan syndrome patients.

P304

3491-3500

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHT334

http://www.w3.org/2001/XMLSchema#string

P433

45

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256377731

http://www.w3.org/2001/XMLSchema#string

P698

23999449

http://www.w3.org/2001/XMLSchema#string